296 related articles for article (PubMed ID: 15811904)
1. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
2. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
3. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
4. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
5. [Caution recommended in prescribing long-acting beta2-adrenergic agonists to patients with asthma].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):889-91. PubMed ID: 16686087
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
7. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
8. Drugs for asthma.
Treat Guidel Med Lett; 2005 May; 3(33):33-8. PubMed ID: 15821635
[TBL] [Abstract][Full Text] [Related]
9. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
11. A safety review of long-acting beta2-agonists in patients with asthma.
Rider NL; Craig TJ
J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
[TBL] [Abstract][Full Text] [Related]
12. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.
Fahy JV; Boushey HA
Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410
[TBL] [Abstract][Full Text] [Related]
13. Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
Prescrire Int; 2007 Apr; 16(88):69-70. PubMed ID: 17458051
[TBL] [Abstract][Full Text] [Related]
14. Benefit-risk assessment of long-acting beta2-agonists in asthma.
Jackson CM; Lipworth B
Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
[TBL] [Abstract][Full Text] [Related]
15. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
Gibson PG; Powell H; Ducharme FM
J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
ten Hacken NH; Kerstjens HA; Postma DS
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
19. Risk versus benefit considerations for the beta(2)-agonists.
Kelly HW
Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
[TBL] [Abstract][Full Text] [Related]
20. Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma.
Nelson HS; Carr W; Nathan R; Portnoy JM
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):11-5. PubMed ID: 19205279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
